ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.707,19
0,48%
S&P 500
5.482,87
0,18%
US Dollar vs BRL
5,4018
-0,44%
Bitcoin
64.557,40
-2,90%
Brent Oil
84,335
0,52%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Phio Pharmaceuticals Corporation (PHIO)

  7. Phio Pharmaceuticals Corporation (PHIO) Notícias

PHIO

Phio Pharmaceuticals (PHIO)

Phio Pharmaceuticals Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PHIO
DataHoraFonteTítuloCódigoCompanhia
28/05/202418:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHIOPhio Pharmaceuticals Corporation
20/05/202418:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PHIOPhio Pharmaceuticals Corporation
20/05/202417:59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:PHIOPhio Pharmaceuticals Corporation
17/05/202410:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PHIOPhio Pharmaceuticals Corporation
17/05/202410:00GlobeNewswire Inc.Phio Pharmaceuticals Secures New InvestorNASDAQ:PHIOPhio Pharmaceuticals Corporation
16/05/202409:00GlobeNewswire Inc.Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)NASDAQ:PHIOPhio Pharmaceuticals Corporation
15/05/202414:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation StudyNASDAQ:PHIOPhio Pharmaceuticals Corporation
09/05/202418:25GlobeNewswire Inc.Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateNASDAQ:PHIOPhio Pharmaceuticals Corporation
09/05/202418:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PHIOPhio Pharmaceuticals Corporation
08/05/202418:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PHIOPhio Pharmaceuticals Corporation
08/05/202418:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PHIOPhio Pharmaceuticals Corporation
08/05/202418:00Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PHIOPhio Pharmaceuticals Corporation
30/04/202408:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)NASDAQ:PHIOPhio Pharmaceuticals Corporation
22/04/202414:10GlobeNewswire Inc.Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsNASDAQ:PHIOPhio Pharmaceuticals Corporation
16/04/202408:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)NASDAQ:PHIOPhio Pharmaceuticals Corporation
11/04/202408:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)NASDAQ:PHIOPhio Pharmaceuticals Corporation
03/04/202408:30GlobeNewswire Inc.National Spotlight Features Phio’s Innovative RNAi Technology PlatformNASDAQ:PHIOPhio Pharmaceuticals Corporation
02/04/202408:30GlobeNewswire Inc.Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business UpdateNASDAQ:PHIOPhio Pharmaceuticals Corporation
21/03/202408:30GlobeNewswire Inc.Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesNASDAQ:PHIOPhio Pharmaceuticals Corporation
13/03/202415:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity ResearchNASDAQ:PHIOPhio Pharmaceuticals Corporation
06/03/202412:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin DisordersNASDAQ:PHIOPhio Pharmaceuticals Corporation
05/03/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PHIOPhio Pharmaceuticals Corporation
06/02/202412:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PHIOPhio Pharmaceuticals Corporation
31/01/202410:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesNASDAQ:PHIOPhio Pharmaceuticals Corporation
28/12/202311:13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PHIOPhio Pharmaceuticals Corporation
28/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PHIOPhio Pharmaceuticals Corporation
19/12/202318:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PHIOPhio Pharmaceuticals Corporation
19/12/202315:07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PHIOPhio Pharmaceuticals Corporation
07/12/202310:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross ProceedsNASDAQ:PHIOPhio Pharmaceuticals Corporation
09/11/202318:30GlobeNewswire Inc.Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:PHIOPhio Pharmaceuticals Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:PHIO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
HAGA3
HAGA ON
BOV
OIBR3
OI ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
SGPS3
SPRINGS ON
BOV
AMAR3
LOJAS MARISA ON
BOV
TELB4
TELEBRAS PN
BOV
TECN3
TECHNOS ON
BOV
JHSF3
JHSF PART ON
BOV
RCSL4
RECRUSUL PN
BOV
QUAL3
QUALICORP ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados